2008-07-15 05:00:00
CHATSWORTH, Calif.–(EMWNews)–North American Scientific (NASDAQ:NASM) announced today that it has
appointed Robin Gibbs to the position of Vice President of Marketing.
Ms. Gibbs, formerly a Vice President of Global Franchise Management for
Edwards Lifesciences, will lead the marketing team for the company’s
growing Radiation Sources division, including the new ClearPath HDR and
ClearPath CR devices which allow customized local radiation dosing for
the breast cancer patient. Ms. Gibbs will report directly to John Rush,
President and CEO of North American Scientific.
“Robin brings 30 years of commercial
experience with clinical diagnostics and medical devices to our
organization,” said Mr. Rush. “Her
global strategic marketing skills will add the appropriate level of
expertise to the senior team as we develop and implement strategies to
expand our business worldwide and prepare for launch of our new
ClearPath products for the Breast Cancer market.”
Ms. Gibbs joins North American Scientific from MedX3, LLC, a marketing
and business development firm where she held a principal position. In
her career, she has held positions with significant responsibility
including roles as Vice President of Global Franchise Management, Vice
President of Global Marketing Cardiovascular Surgery, Vice president of
Global Marketing Heart Valve Therapy, and Director of National Accounts.
Ms. Gibbs began her career in sales and sales management positions with
American Hospital Supply and Baxter Healthcare.
About North American Scientific
North American Scientific is a medical device company focused on
developing products which deliver local controlled radiation therapy for
cancer. Its innovative products allow patients to be treated effectively
with a shortened course of treatment and reduced side effects. Current
products include the Prospera® Iodine and
Palladium seeds and SurTRAK™ needles and
strands used primarily in the treatment of prostate cancer.
Additionally, the Company has been gaining clinical experience with its
ClearPath™ multi-channel catheter device for
local radiation delivery in the breast cancer patient. The ClearPath
family of products are the only such devices approved for both high dose
and continuous release, or low dose, local radiation treatments for
breast cancer. The devices are designed to provide flexible, precise
dose customization and unparalleled patient comfort in a shortened,
effective course of treatment. Please visit www.nasmedical.com
for more information.
|
North American Scientific |
|
Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89
Get Unlimited Organic Website Traffic to your Website
TheNFG.com now offers Organic Lead Generation & Traffic Solutions
